GoodRx Holdings, Inc.GDRX
Price (close)
$3.36
Market cap
$1.2B
P/E
72.0x
Revenue (TTM)
$785.2M
Net income
$16.2M
Dividend yield
—
1-year total return
-14.5%
Net margin
2.1%
Revenue growth
-1.8%
Debt / equity
0.75x
What GoodRx Holdings, Inc. does.
prescriptions, offering consumers free access to lower prices on their medication. This price comparison platform processes
telehealth services, and wellness related content. We believe that our offerings provide significant savings to consumers,
stages of the consumer healthcare journey, enabling us to drive higher expected consumer lifetime value without significant
Revenue and profit, by fiscal year.
| Fiscal year | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | $550.7M | $745.4M | $766.6M | $750.3M | $792.3M | $796.9M |
| Net income | -$293.6M | -$25.3M | -$32.8M | -$8.9M | $16.4M | $30.4M |
| Free cash flow | $110.8M | $174.2M | $142.8M | $137.2M | $182.7M | $164.4M |
More on GDRX.
- GoodRx Holdings, Inc. summary
- GoodRx Holdings, Inc. financial statements
- GoodRx Holdings, Inc. key metrics
- GoodRx Holdings, Inc. health scores and style box
- GoodRx Holdings, Inc. earnings
- GoodRx Holdings, Inc. dividends
- GoodRx Holdings, Inc. valuation
- GoodRx Holdings, Inc. ownership and insiders
- GoodRx Holdings, Inc. peers
Figures from GoodRx Holdings, Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.